RubiconMD, Inc. — Form D
RubiconMD, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2020-02-24. The offering totals $18.0M, of which $16.0M was reported sold. Industry: Other Technology.
Offering
- Filed: 2020-02-24
- Form: D
- Accession: 0001804151-20-000001
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $18.0M
- Amount sold: $16.0M
- Remaining: $2.0M
- Investors: 10
- Date of first sale: 2020-02-07
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-361237
Issuer
- Name: RubiconMD, Inc.
- CIK: 0001804151
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 330 HUDSON STREET, SUITE 302, NEW YORK, NY, 100013
- Phone: 6176489100
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Gilbert Addo | Director | New York, NY |
| Enrico Picozza | Director | Edison, NJ |
| Carlos Reines | Director | New York, NY |
| Rajeev Singh-Morales | Director | New York, NY |
| Laura Veroneau | Director | Carlsbad, CA |
| Gilbert Addo | Executive Officer | New York, NY |
More